Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology

被引:4
|
作者
Qiang, Rui [1 ]
Zhang, Ya [1 ,2 ]
Wang, Yanhong [3 ,4 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] Shaanxi Univ Chinese Med, Xianyang 712046, Peoples R China
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Orthoped, Shanghai 200065, Peoples R China
[4] Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regene, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN; 90; INHIBITOR; LIVER FIBROSIS; BETA-SITOSTEROL; STELLATE CELLS; QUERCETIN; PREDICTION; INJURY; INFLAMMATION; PROGRESSION; DOCKING;
D O I
10.1155/2022/8925637
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose. To explore the material basis and pharmacological mechanism of Xiaochaihu Decoction (XCHD), the classic Traditional Chinese Medicine (TCM) formula in inhibiting hepatic fibrosis (HF). Methods. The main components in XCHD were screened from the TCMSP database, ETCM database, and literature, and their potential targets were detected and predicted using the Swiss Target Prediction platform. The HF-related targets were retrieved and screened through GeneCard database and OMIM database, combined with GEO gene chips. The XCHD targets and HF targets were mapped to search common targets. The protein-protein interaction (PPI) network was acquired via the STRING11.0 database and analyzed visually using Cytoscape 3.8.0 software. The potential mechanisms of the common targets identified through GO and KEGG pathway enrichment analysis were analyzed by using Metascape database. The results were visualized through OmicShare Tools. The "XCHD compound-HF target" network was visually constructed by Cytoscape 3.8.0 software. AutoDockVina1.1.2 and PyMoL software were used to verify the molecular docking of XCHD main active compounds and HF key targets. Results. A total of 164 potential active compounds from XCHD were screened to act on 95 HF-related targets. Bioinformatics analysis revealed that quercetin, beta-sitosterol, and kaempferol may be candidate agents, which acted on multiple targets like PTGS2, HSP90AA1, and PTGS1 and regulate multiple key biological pathways like IL-17 signaling pathway, TNF signaling pathway and PI3K-Akt signaling pathway to relieve HF. Moreover, molecular docking suggested that quercetin and PTGS2 could statically bind and interact with each other through amino acid residues val-349, LEU-352, PHE-381, etc. Conclusion. This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects from the bioactive ingredients. This study could be one of the cornerstones for further research.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The mechanisms of Huangqi Guizhi Wuwu decoction in treating ischaemic stroke based on network pharmacology and experiment verification
    Liao, Weiguo
    Wang, Minchun
    Wu, Ying
    Du, Jinyan
    Li, Yaxin
    Su, Anyu
    Zhong, Lanying
    Xie, Zi
    Gong, Mingyu
    Liang, Junhui
    Wang, Pengcheng
    Liu, Zai
    Wang, Lisheng
    PHARMACEUTICAL BIOLOGY, 2023, 61 (01) : 1014 - 1029
  • [22] Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia
    Xu, Jingnan
    Bai, Chen
    Huang, Ling
    Liu, Tiegang
    Wan, Yuxiang
    Zheng, Zian
    Ma, Xueyan
    Gao, Fei
    Yu, He
    Gu, Xiaohong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01)
  • [23] Decoding the underlying mechanisms of Di-Tan-Decoction in treating intracerebral hemorrhage based on network pharmacology
    Zhen, Zheng
    Xue, Dao-jin
    Chen, Yu-peng
    Li, Jia-hui
    Gao, Yao
    Shen, You-bi
    Peng, Zi-zhuang
    Zhang, Nan
    Wang, Ke-xin
    Guan, Dao-gang
    Huang, Tao
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [24] Integrated Network Pharmacology and Proteomic Analyses of Targets and Mechanisms of Jianpi Tianjing Decoction in Treating Vascular Dementia
    Liu, Jidan
    Gong, Juanfen
    Xu, Jinchao
    Fang, Mengyuan
    Su, Meng
    Li, Weiguang
    Wu, Yiyi
    Hui, Yang
    He, Yingchun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2023, 2023
  • [25] Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia
    Jingnan Xu
    Chen Bai
    Ling Huang
    Tiegang Liu
    Yuxiang Wan
    Zian Zheng
    Xueyan Ma
    Fei Gao
    He Yu
    Xiaohong Gu
    BMC Complementary Medicine and Therapies, 20
  • [26] Decoding the underlying mechanisms of Di-Tan-Decoction in treating intracerebral hemorrhage based on network pharmacology
    Zheng Zhen
    Dao-jin Xue
    Yu-peng Chen
    Jia-hui Li
    Yao Gao
    You-bi Shen
    Zi-zhuang Peng
    Nan Zhang
    Ke-xin Wang
    Dao-gang Guan
    Tao Huang
    BMC Complementary Medicine and Therapies, 23
  • [27] Mechanisms of Tripterygium wilfordii Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking
    Mao, Ni
    Xie, Xi
    OPEN MEDICINE, 2024, 19 (01):
  • [28] Network Pharmacology Study of Yuebi Plus Banxia Decoction in Treating Asthma
    Wen-Jie Song
    Zheng Hao
    WorldJournalofTraditionalChineseMedicine, 2021, 7 (03) : 370 - 376
  • [29] Network Pharmacology Study of Yuebi Plus Banxia Decoction in Treating Asthma
    Song, Wen-Jie
    Hao, Zheng
    WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2021, 7 (03) : 370 - 376
  • [30] Network pharmacology and LC-MS approachs to explore the active compounds and mechanisms of Yuanjiang decoction for treating bradyarrhythmia
    Wang, Xujie
    Zhang, Xuexue
    Li, Jiaxi
    Fu, Jinyi
    Zhao, Mengjie
    Zhang, Wantong
    Weng, Weiliang
    Li, Qiuyan
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 152